2016 annual financial data

Viridian Therapeutics 2016 Net margin

Direct answer

Net margin was -379.8%.

Operating income was -12,508,000 USD and net income was -12,674,000 USD.
Operating cash flow was -7,231,000 USD.

Get free Viridian Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
3,337,000 USD
Operating income
-12,508,000 USD
Net income
-12,674,000 USD
Operating cash flow
-7,231,000 USD